News & Events

Survey of Immuno-oncology Clinical

Studies in ClinicalTrials.gov

Teresa Piliouras, Pui Lam Yu, Kangji Liu, Liza Salloum, Shrinivas Shetty, Jiuchen Zhang, Bhargav Kalluri, Shuhui Guo, Xiaoyu He, Chuxuan Sora Jin, Michael Herman, Zhitao Ma

​

This presentation describes methods to extract and analyze data on immuno-oncology research trials from ClinicalTrials.gov. A long and ever-expanding list of search terms is needed to cast the widest possible net for all immuno-oncology studies requires. This reflects the evolution of traditional immuno-therapies (checkpoint inhibitors; cellular therapies) and the emergence of new types of targeted therapies (Bacillus Calmette-Guerin for bladder cancer; microbiome; antigen therapy; T-cell therapy; etc.). We present a series of graphical displays illustrating the evolution of immuno-oncology clinical trials. Clinical trials using immuno-therapies for solid tumors, breast cancer, and prostate cancer are highlighted. Our goal is to promote greater awareness of developments in immuno-oncology research, and opportunities to participate in clinical trials.

To view our results, go to our interactive website: https://lnkd.in/g2HF_a